focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDunelm Regulatory News (DNLM)

Share Price Information for Dunelm (DNLM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,014.00
Bid: 1,014.00
Ask: 1,017.00
Change: -9.00 (-0.88%)
Spread: 3.00 (0.296%)
Open: 1,020.00
High: 1,024.00
Low: 1,013.00
Prev. Close: 1,023.00
DNLM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

B/C SHARE SCHEME - PURCHASE OFFER

11 Mar 2015 08:00

RNS Number : 0877H
Dunelm Group plc
11 March 2015
 



 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, NEW ZEALAND, JAPAN OR THE REPUBLIC OF SOUTH AFRICA.

 

 

Dunelm Group plc

 

(the 'Company')

 

11 March 2015

 

B/C SHARE SCHEME - PURCHASE OFFER

 

 

UBS Limited ('UBS') hereby makes the Purchase Offer, acting as principal (and not as agent, nominee or trustee), to purchase 73,756,725 C Shares that were issued pursuant to the B/C Share Scheme. Under the Purchase Offer, which is being made in the manner and on the terms set out in the circular published by the Company on 12 February in relation to the B/C Share Scheme (the 'Circular'), UBS will purchase such C Shares for 70 pence per C Share, free of all dealing expenses and commissions.

 

It is expected that Shareholders entitled to receive payments in respect of the proceeds of sale of C Shares to UBS under the Purchase Offer will be sent cheques or, if Shareholders held their Ordinary Shares in CREST, will have their CREST accounts credited by 24 March 2015.

 

UBS hereby gives notice, acting as principal (and not as agent, nominee or trustee), that it has received written notice from the Company requesting it to purchase on 11 March 2015 all of the Deferred Shares in issue into which B Shares have been automatically reclassified, in accordance with the terms set out in the Circular, for an aggregate consideration of one penny. Accordingly UBS will purchase such Deferred Shares today.

 

Unless the context otherwise requires, capitalised terms used in this announcement shall have the same meaning ascribed to them in the Circular.

 

The Circular is available in the investor section of the Company's website at www.dunelm.com.

 

 

Enquiries:

 

 

Dunelm Group plc 0116 2644 356

Will Adderley, Chief Executive

David Stead, Finance Director

 

MHP Communications 020 3128 8100

John Olsen

Simon Hockridge

Naomi Lane

 

 

This announcement does not constitute an offer to sell or the solicitation of an offer to buy any security, nor the solicitation of any vote or approval in any jurisdiction, nor shall there be any sale, issuance or transfer of the securities referred to in any jurisdiction in contravention of applicable law.

 

None of the B Shares, the C Shares or the Deferred Shares have been or will be registered under the US Securities Act or the state securities laws of the United States and none of them may be offered or sold in the United States unless pursuant to a transaction which has been registered under the US Securities Act and/or relevant state securities laws or which is not subject to the registration requirements of the US Securities Act or such laws, either because of an exemption therefrom or otherwise.

 

None of the B Shares, the C Shares or the Deferred Shares or this announcement or the Circular has been approved, disapproved or otherwise recommended by any US federal or state securities commission or other regulatory authority or any non-US securities commission or regulatory authority nor have any such authorities confirmed the accuracy or determined the adequacy of this announcement or the Circular. Any representation to the contrary is a criminal offence in the United States.

 

UBS Limited is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and Prudential Regulation Authority and is acting as financial adviser to Dunelm in connection with the Return of Capital and for no one else and will not be responsible to anyone other than Dunelm (whether or not a recipient of this announcement of the Circular) for providing the protections afforded to clients of UBS Limited nor for providing advice in relation to the proposals described in this announcement or the Circular or any other matter referred to in this announcement or the Circular. Persons other than Dunelm are recommended to seek their own financial and professional advice.

 

Apart from the responsibilities and liabilities, if any, which may be imposed on UBS Limited by the FSMA or the regulatory regime established thereunder, UBS Limited accepts no responsibility or liability whatsoever for the contents of this announcement or the Circular or for any other statement made or purported to be made in connection with the Company or the proposed Return of Capital. UBS Limited accordingly disclaims all and any responsibility or liability whether arising in tort, contract or otherwise (save as referred to above) which it might otherwise have in respect of this announcement, the Circular or any such statement.

 

This announcement has been issued by, and is the sole responsibility of, the Company.

 

Name of authorised Company official responsible for making this notification:

 

Dawn Durrant, Company Secretary

 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAXDEFAKSEFF
Date   Source Headline
30th Jul 20217:00 amRNSTotal Voting Rights
14th Jul 20217:00 amRNSDirectorate Change
14th Jul 20217:00 amRNSFourth quarter trading update
12th Jul 20215:37 pmRNSHolding(s) in Company
8th Jul 20217:00 amRNSHolding(s) in Company
30th Jun 20217:00 amRNSTotal Voting Rights
28th May 20217:00 amRNSTotal Voting Rights
19th May 20217:00 amRNSTrading Update
10th May 20217:00 amRNSTargets for long term share incentive awards
30th Apr 20217:00 amRNSTotal Voting Rights
26th Apr 20217:00 amRNSDirectorate Change
14th Apr 20217:00 amRNSBlock listing Interim Review
14th Apr 20217:00 amRNSBlock listing Interim Review
14th Apr 20217:00 amRNSBlock listing Interim Review
14th Apr 20217:00 amRNSBlock listing Interim Review
8th Apr 20217:00 amRNSThird quarter trading update
31st Mar 20217:00 amRNSTotal Voting Rights
3rd Mar 20217:00 amRNSDirector/PDMR Shareholding
26th Feb 20217:00 amRNSTotal Voting Rights
16th Feb 20215:30 pmRNSDunelm Group
16th Feb 20217:01 amRNSHolding(s) in Company
16th Feb 20217:00 amRNSResults of Secondary Placing
15th Feb 20214:45 pmRNSProposed Secondary Placing
15th Feb 20217:00 amRNSConfirmation of Board Changes
12th Feb 20217:00 amRNSDirector/PDMR Shareholding
10th Feb 20217:00 amRNSInterim Results
29th Jan 20217:00 amRNSTotal Voting Rights
14th Jan 20217:00 amRNSAppointment of Non-Executive Director
14th Jan 20217:00 amRNSSecond quarter trading update
31st Dec 20207:00 amRNSTotal Voting Rights
30th Nov 20207:00 amRNSTotal Voting Rights
23rd Nov 20207:00 amRNSShare incentive awards
17th Nov 20201:00 pmRNSResult of AGM
5th Nov 20207:00 amRNSUpdate on latest Coronavirus restrictions
30th Oct 20207:00 amRNSTotal Voting Rights
28th Oct 20207:00 amRNSImportant information relating to the AGM
15th Oct 20207:00 amRNSFirst quarter trading update
13th Oct 20207:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
13th Oct 20207:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
13th Oct 20207:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
13th Oct 20207:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
9th Oct 20207:00 amRNSAnnual Financial Report
30th Sep 20207:00 amRNSTotal Voting Rights
16th Sep 20207:00 amRNSDirector/PDMR Shareholding
10th Sep 20207:01 amRNSConfirmation of Board change
10th Sep 20207:00 amRNSFinal Results
1st Sep 20207:00 amRNSTrading Update
28th Aug 20207:00 amRNSTotal Voting Rights
31st Jul 20207:00 amRNSTotal Voting Rights
15th Jul 20207:00 amRNSFourth Quarter Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.